Scientific Library
- Acute Coronary Syndrom
- ASCVD Prevention
- Bifurcation Stenting
- Cardio-Oncology
- Congestive Heart Failure
- DAPT Duration
- Drug Coated Balloon
- Fractional Flow Reserve
- IVUS Guidance
- Optical Coherence Tomography
- Pulmonary Hypertension
- Rotational Atherectomy
- Shear Stress
- Stenting Left Main
- Transcatheter Aortic Valve Replacement
- Percutaneous LAA Occlusion
- Mitral/Tricuspid Valvular Disease
- Other Relevant Articles
-
Restenosis, Stent Thrombosis, and Bleeding Complications - Navigating Between Scylla and CharybdisJ Torrado, L Buckley, A Durán et al. -
Symptom-Onset-To-Balloon Time, ST-Segment Resolution and In-Hospital Mortality in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention in China: From China Acute Myocardial Infarction RegistryYang Y, CAMI Registry study group.
-
Aggressive lipid-lowering therapy after percutaneous coronary intervention – for whom and how?Z-V Lee.
-
Non-eligibility for reperfusion therapy in patients presenting with ST-segment elevation myocardial infarction: Contemporary insights from the National Cardiovascular Data Registry (NCDR)Dasari TW, Hamilton S, Chen AY et al.
-
Anticoagulation combined with antiplatelet therapy in patients with left ventricular thrombus after first acute myocardial infarctionManiwa N, Fujino M, Nakai M et al.
-
Coronary Catheterization and Percutaneous Coronary Intervention in China: 10-Year Results From the China PEACE-Retrospective CathPCI StudyZheng X, Curtis JP, China PEACE Collaborative Group
-
1-Year Outcomes of Patients Undergoing Primary Angioplasty for Myocardial Infarction Treated With Prasugrel Versus TicagrelorMotovska Z, Hlinomaz O, PRAGUE-18 Study Group et al.
-
Effect of alirocumab on major adverse cardiovascular events according to renal function in patients with a recent acute coronary syndrome: prespecified analysis from the ODYSSEY OUTCOMES randomized clinical trialJ Tuñón, PG Steg, ODYSSEY OUTCOMES Investigators et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
